about
AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia.Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology.Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response.Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study.Hepatopathy-thrombocytopenia syndrome (HTS) after actinomycin-D therapy: report of three cases and review of the literature.Effectiveness of cyclosporine and mycophenolate mofetil in a child with refractory evans syndrome.Efficacy of combined intravenous immunoglobulins and steroids in children with primary immune thrombocytopenia and persistent bleeding symptomsCerebral Stroke in a Teenage Girl with Paroxysmal Nocturnal Hemoglobinuria.Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology.Diagnosis and management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the Red Cell Study Group of the Paediatric Haemato-Oncology Italian AssociationDiagnosis and management of primary autoimmune neutropenia in children: insights for clinicians.Fanconi anemia patients are more susceptible to infection with tumor virus SV40Castleman's disease in childhood: report of three cases and review of the literatureIdentification of point mutations and large intragenic deletions in Fanconi anemia using next-generation sequencing technologyAbdomen/pelvis computed tomography in staging of pediatric Hodgkin Lymphoma: is it always necessary?FIP1L1-PDGFRα-positive hypereosinophilic syndrome in childhood: a case report and review of literature.Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma.Immune neutropenias of infancy and childhood.A retrospective study of paroxysmal nocturnal hemoglobinuria in pediatric and adolescent patients.Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.Plasma cell-free DNA in paediatric lymphomas.The prognostic value of biological markers in paediatric Hodgkin lymphoma.Treatment of human papillomavirus infection with interferon alpha and ribavirin in a patient with acquired aplastic anemia.Vocal cord palsy after vincristine treatment in a child and the inefficacy of glutamic acid in the prevention of relapse: a case report.Infectious complications in children with severe congenital, autoimmune or idiopathic neutropenia: a retrospective study from the Italian Neutropenia Registry.Hodgkin lymphoma and nephrotic syndrome in childhood.Autoimmune neutropenia of infancy: Data from the Italian neutropenia registry.Hypereosinophilic syndrome in childhood: clinical and molecular features of two cases.Autoimmune neutropenia of childhood secondary to other autoimmune disorders: Data from the Italian neutropenia registry.Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica).HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma.Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma.Ataluren-driven Restoration of Shwachman-Bodian-Diamond Syndrome Protein Function in Shwachman-Diamond Syndrome Bone Marrow Cells.Hypomorphic FANCA mutations correlate with mild mitochondrial and clinical phenotype in Fanconi anemia.Diagnostic value of cell bound and circulating neutrophil antibody detection in pediatric neutropenia.Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica).Reversible posterior leukoencephalopathy syndrome: report of 2 simultaneous cases in children.Long-term results of the AIEOP MH'96 childhood Hodgkin's lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy.Pearson syndrome.Bone marrow histology for the diagnosis of essential thrombocythemia in children: a multicenter Italian study.
P50
Q30371243-7313A4E8-87DE-4FD5-8FC0-4F8284EE0343Q31116844-A716F270-6A68-4067-B1C1-C07C47315137Q33382172-D84CE370-14CC-46B2-B30E-C6C553807DA5Q33391827-D3D9E2E2-D3F8-40A8-AFF0-746CED2F09E3Q33393867-29E2CBFC-B9A1-40F6-9E54-28A173F61ABBQ33396299-2D66CBF9-395E-4289-94A8-799290A6ED6CQ33415659-ACA76FF6-D62B-4B70-9652-E94A15C7FD09Q33442790-9D72D32E-B058-4BF4-9285-C2CB20C9AF8FQ33695948-33DE60E1-FFAA-4AE2-B749-1D72D3A5BCBBQ33739534-9861EACB-C9EC-4B14-AA2C-07738F7B7E0DQ34982988-57319544-999A-44B2-971C-105CBA150634Q35048631-107B5802-7356-40BE-A44F-DC2C1C71501EQ35560071-72FF0651-DC65-43FC-A980-A033E940B60FQ36411281-6EB2AD64-72DC-40B5-8FCB-361CE0ABCB53Q37321020-4E944534-9AE2-4E85-974B-4594F61893C7Q38075703-033FF438-095E-4EA7-90D0-3A70203BC08DQ38355142-722D2416-E0E5-4C35-8A93-A4E13BBE8BA5Q38637993-6DB11F0B-D6A3-4E0C-BD28-5CF0C933650EQ40263326-431A18E3-59E6-4BF9-A1A7-7A7EF3E1E4D2Q40513679-7A8212F4-3909-451F-87ED-9F54C99D75D3Q40721870-059013CF-7904-4017-B372-56A53856A261Q41078618-23D86F4D-5A7F-46CF-AD19-7DAACEEE5E35Q42229453-DB8B6396-E30A-4CDB-AEC7-F27335FC5778Q42254377-1A6F0962-301B-4029-A49B-7152D069CA12Q42282260-897FC19E-AEFE-4C18-BE25-1ACD0731A3D5Q42876193-3596537B-2269-444B-A618-AD3E7FAF16C6Q44668156-F802917A-1D9B-401D-9C7C-478D25905D97Q46042993-BCEE7899-23D4-4918-B01E-513C630D1171Q46268308-525E1AC2-DAC8-45BF-B0A5-45299D196FBAQ46478431-8215C892-9B07-40A5-8584-16FA9BE5DBC0Q47098973-F708B3FA-7B13-4152-A471-3F2C31951E83Q47120665-B6E98CB4-2DF4-441D-87D7-AD62C6EFAA0BQ47247014-ACD39996-4E3C-40CC-A610-DED2F59781ECQ47262970-9BB763B9-5AA7-4B26-BC5A-3C43C2FEE1C3Q48135851-0BDAA0B9-E861-4680-9689-E0670FF4ECA4Q48160900-E779015F-1F0C-488C-A8D0-9B925B800596Q48551474-026318A4-CAA5-4704-AB28-F36D7C324940Q49963473-6626D7D6-4947-473D-8B86-A37AE26852C3Q50027812-2CA837DE-3846-4C21-AD9C-8C7A3FFCAC1DQ52881169-07FA40FA-F700-4A22-80E0-8C2866BCE6F5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Piero Farruggia
@ast
Piero Farruggia
@en
Piero Farruggia
@es
Piero Farruggia
@nl
type
label
Piero Farruggia
@ast
Piero Farruggia
@en
Piero Farruggia
@es
Piero Farruggia
@nl
prefLabel
Piero Farruggia
@ast
Piero Farruggia
@en
Piero Farruggia
@es
Piero Farruggia
@nl
P106
P1153
8917481400
P31
P496
0000-0002-3412-0399